Home

Novartis India Ltd PE Ratio

Image

Novartis India Ltd

NSE: NOVARTIND

PE

23

Last updated on: Apr 02, 2025

Key Highlights

  • The P/E Ratio of Novartis India Ltd is 23 as of 02 Apr 9.00 AM .
  • The P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 29.8 on March 2024 . This represents a CAGR of -24.70% over 5 years.
  • The Latest Trading Price of Novartis India Ltd is ₹ 803.25 as of 02 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Novartis India Ltd

No data available

Company Fundamentals for Novartis India Ltd

Image

Novartis India Ltd

NSE: NOVARTIND

Share Price

₹ 803.25

-4.40 (-0.54%)

stock direction

Last updated on: Apr 02, 2025

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 2025803.25
01 Apr 2025807.65
28 Mar 2025785.05
27 Mar 2025807.1
26 Mar 2025830.1
25 Mar 2025830
24 Mar 2025837.45
21 Mar 2025842
20 Mar 2025788.45
19 Mar 2025767

SWOT Analysis Of Novartis India Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Novartis India Ltd

Asset Value vs Market Value of Novartis India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Novartis India Ltd1983
Sun Pharmaceutical Industries Ltd411306
Divis Laboratories Ltd150343
Cipla Ltd117323
Torrent Pharmaceuticals Ltd108614
Mankind Pharma Ltd99891

PE Ratio of Novartis India Ltd Explained

1983

Market cap

86

Earnings

23.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Novartis India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Novartis India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Novartis India Ltd

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

Novartis India Ltd News Hub

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024. Powe

Read more

28 Sept 24

Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 a

Read more

25 Oct 24

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

28 Dec 24

Novartis India standalone net profit declines 4.22% in the December 2024 quarter

Net profit of Novartis India declined 4.22% to Rs 25.45 crore in the quarter ended December 2024 as

Read more

28 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Novartis India Ltd

What is the current PE Ratio of Novartis India Ltd?

The Current PE Ratio of Novartis India Ltd is 22.99 as on 2 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 2 Apr 2025.

What was the PE Ratio of Novartis India Ltd last year?

The PE Ratio of Novartis India Ltd was 13.5 last year, now the PE ratio is 22.99, showing a year-on-year growth of 70.3%.

What does the PE Ratio of Novartis India Ltd indicate about its stock?

The PE Ratio of Novartis India Ltd is 22.99. This ratio indicates that investors are willing to pay 22.99 times the earnings per share for each share of Novartis India Ltd.

What is the PE Ratio Growth of Novartis India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Novartis India Ltd grew by 70.3% whereas, the EPS ratio grew by 24.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions